SGR-1505

N/A

Report date: 2025/07/15 11:53:15
NME

Base Information

Drug NameSGR-1505
Drug Alias NameSGR-1505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMucosa-associated lymphoid tissue lymphoma translocation protein 1 inhibitors
TargetsMucosa-associated lymphoid tissue lymphoma translocation protein 1
Therapy Area/IndicationsPrimary mediastinal B cell lymphomaWaldenstrom MacroglobulinemiaLymphoma, T-Cell +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkrainePoland +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSchrodinger Inc
China Registration ClassN/A

Develop Information

Active CompaniesSchrodinger IncSchrödinger Inc
Inactive CompaniesN/A
Active IndicationsPrimary mediastinal B cell lymphomaWaldenstrom MacroglobulinemiaLymphoma, T-Cell +[14] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A